XML 88 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
May 31, 2018
Derivatives [Line Items]        
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments $ (1.8) $ (12.2)    
Gains (losses) on net investment hedges, net of tax $ 0.0 6.2    
Minimum        
Derivatives [Line Items]        
Range of durations of foreign currency forward contracts 1 month   1 month  
Maximum        
Derivatives [Line Items]        
Range of durations of foreign currency forward contracts 18 months   12 months  
Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount $ 1,436.3   $ 1,238.8  
Other current assets | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative asset, fair value 12.3   37.9  
Other current assets | Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative asset, fair value 22.7   25.1  
Other noncurrent assets | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative asset, fair value 0.1   0.0  
Accrued expenses and other | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative liability, fair value 31.9   18.4  
Accrued expenses and other | Not designated as hedging instrument        
Derivatives [Line Items]        
Derivative liability, fair value 7.6   7.6  
Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 2,270.6   1,715.5  
Foreign Exchange Forward        
Derivatives [Line Items]        
Unrealized Gain on Derivatives 8.8 29.9    
Unrealized Loss on Derivatives (39.0) (21.3)    
Unrealized Gain (Loss) on Derivatives (30.2) 8.6    
Net Investment Hedging        
Derivatives [Line Items]        
Gains (losses) on net investment hedges, net of tax   10.1    
Gains (losses) on net investment hedge, excluded component   (3.3)    
Cash Flow Hedging [Member] | Foreign exchange contract | Other long-term liabilities        
Derivatives [Line Items]        
Derivative liability, fair value 0.3   0.0  
Revenue | Foreign exchange contract        
Derivatives [Line Items]        
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 17.6 20.9    
Revenue | Cash flows, revenue | Foreign exchange contract        
Derivatives [Line Items]        
Gain on interest rate swap 1.6 (6.5)    
Operating expense | Foreign exchange contract        
Derivatives [Line Items]        
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax (0.5) (0.3)    
Operating expense | Cash flows, operating expenses | Foreign exchange contract        
Derivatives [Line Items]        
Gain on interest rate swap (2.1) (0.1)    
Other income (expense) | Net Investment Hedging        
Derivatives [Line Items]        
Gain (loss) recognized in net income, excluded component   $ (1.1)    
Euro | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 1,854.8   1,495.5  
Swiss franc | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 124.3   162.8  
Japan, Yen | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount 43.3   57.2  
Canadian dollar | Foreign exchange contract | Designated as hedging instrument        
Derivatives [Line Items]        
Derivative, Notional Amount $ 248.2   $ 0.0  
Samsung Bioepis        
Derivatives [Line Items]        
Equity, ownership interest 49.90% 49.90%    
Percentage of stake in entity       5.00%
Short-term derivative        
Derivatives [Line Items]        
Range of durations of foreign currency forward contracts 12 months      
Gain/Loss on fair value of foreign currency forward contracts $ 30.0